Taurine 8 pp 29-38 | Cite as

Lethality of Taurine and Alcohol Coadministration in Mice

  • Andrey G. Taranukhin
  • Pirjo Saransaari
  • Simo S. Oja
Conference paper
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 776)

Abstract

Alcohol consumption by mothers during pregnancy causes a fetal alcohol syndrome associated with massive neuronal apoptosis. We have recently shown that taurine at a dose of 2 g/kg saves about 50% of dying cerebellar neurons from ethanol-induced apoptosis in 7-day-old mice. However, a further increase in the taurine dose to ethanol-treated mice had a toxic and in some cases lethal effect. In the present work we studied the toxic effects of taurine and ethanol coadministration in three age groups: 7-day-old, adult (5 to 6 months old), and old (12 to 13 months old) mice. Taurine and ethanol were injected in two half-doses: taurine at 0 and 4 h and ethanol at 1 and 3 h. The minimal 100% lethal doses in coadministration of taurine and ethanol were the following: 7-day-old mice—6 g/kg taurine + 5 g/kg ethanol, adult mice—10 g/kg of taurine + 8 g/kg of ethanol, and old mice—above 6 g/kg of taurine + 6 g/kg of ethanol. All mice treated with taurine or ethanol alone survived. The adult and old mice dying from the combined toxicity of taurine and ethanol showed a marked fall in blood glucose, which may be one reason for lethality. A comparison of the lethal doses of taurine and ethanol coadministration in different age groups allows us to conclude that the adverse effect of the combined toxicity of taurine and ethanol is age dependent.

References

  1. Anderzhanova E, Saransaari P, Oja SS (2006) Neuroprotective mechanisms of taurine in vivo. Adv Exp Med Biol 583:377–387PubMedCrossRefGoogle Scholar
  2. Birdsall TC (1998) Therapeutic application of taurine. Altern Med Rev 3:128–136PubMedGoogle Scholar
  3. Chudley AE, Conry J, Cook JL, Loock C, Rosales T, LeBlanc N (2005) Public Health Agency of Canada’s National Advisory Committee on Fetal Alcohol Spectrum Disorder, Fetal alcohol spectrum disorder: Canadian guidelines for diagnosis. Can Med Ass J 172(5 Suppl):S1–S21CrossRefGoogle Scholar
  4. Das J, Ghosh J, Manna P, Sinha M, Sil PC (2009) Taurine protects rat testes against NaAsO2 -induced oxidative stress and apoptosis via mitochondrial dependent and independent pathways. Toxicol Lett 187:201–210PubMedCrossRefGoogle Scholar
  5. Dikranian K, Qin YQ, Labruyere J, Nemmers B, Olney JW (2005) Ethanol-induced neuroapoptosis in the developing rodent cerebellum and related brain stem structures. Brain Res Dev Brain Res 155:1–13PubMedCrossRefGoogle Scholar
  6. Eustace LW, Kang DH, Coombs D (2003) Fetal alcohol syndrome: a growing concern for health care professionals. J Obstet Gynecol Neonatal Nurs 32:215–221PubMedCrossRefGoogle Scholar
  7. Farber NB, Creeley CE, Olney JW (2010) Alcohol-induced neuroapoptosis in the fetal macaque brain. Neurobiol Dis 40:200–206PubMedCrossRefGoogle Scholar
  8. Goldberg AA, Jefferies HS (1946) Potentiation of insulin hypoglycaemia by nicotinyl taurine (beta-nicotinamidoethanesulphonic acid). Q J Pharm Pharmacol 19:48–53PubMedGoogle Scholar
  9. Hao HN, Parker GC, Zhao J, Barami K, Lyman WD (2003) Differential responses of human neural and hematopoietic stem cells to ethanol exposure. J Hematother Stem Cell Res 12:389–399PubMedCrossRefGoogle Scholar
  10. Hotchkiss RS, Strasser A, McDunn JE, Swanson PE (2009) Cell death. N Engl J Med 361:1570–1583PubMedCrossRefGoogle Scholar
  11. Huang Z, Sjöholm A (2008) Ethanol acutely stimulates islet blood flow, amplifies insulin secretion, and induces hypoglycemia via nitric oxide and vagally mediated mechanisms. Endocrinology 149:232–236PubMedCrossRefGoogle Scholar
  12. Huxtable RJ (1992) Physiological actions of taurine. Physiol Rev 72:101–163PubMedGoogle Scholar
  13. Ikonomidou C, Bittigau P, Ishimaru MJ, Wozniak DF, Koch C, Genz K, Price MT, Stefovska V, Hörster F, Tenkova T, Dikranian K, Olney JW (2000) Ethanol-induced apoptotic neurodegeneration and fetal alcohol syndrome. Science 287:1056–1060PubMedCrossRefGoogle Scholar
  14. Kaplan B, Karabay G, Zağyapan RD, Ozer C, Sayan H, Duyar I (2004) Effects of taurine in glucose and taurine administration. Amino Acids 27:327–333PubMedCrossRefGoogle Scholar
  15. Kihara K, Yasugi D, Kuwahara Y, Kakigi K, Isaka K, Tsuji K, Hagino T, Kuroda S, Habuchi M, Ishigami M, Fujii R, Hasegawa M, Araki H (1991) Single dose toxicity study of taurine in rat. Jpn Pharamcol Ther 19:263–268Google Scholar
  16. Kulakowski EC, Maturo J (1984) Hypoglycemic properties of taurine: not mediated by enhanced insulin release. Biochem Pharmacol 33:2835–2838PubMedCrossRefGoogle Scholar
  17. Lallemand F, De Witte P (2004) Taurine concentration in the brain and in the plasma following intraperitoneal injections. Amino Acids 26:111–116PubMedCrossRefGoogle Scholar
  18. Lourenco R, Camilo ME (2002) Taurine: a conditionally essential amino acid in humans? An overview in health and disease. Nutr Hosp 17:262–270PubMedGoogle Scholar
  19. Nakagawa K, Kuriyama K (1975) Effect of taurine on alteration in adrenal functions induced by stress. Jpn J Pharmacol 25:737–746PubMedCrossRefGoogle Scholar
  20. Nishizawa Y, Yamamuro H, Kikumori M, Toda T, Araki H (1991) Single dose toxicity study of an intravenous treatment with taurine in dog. Jpn Pharmacol Ther 19:269–274Google Scholar
  21. Oja SS, Saransaari P (2007) Pharmacology of taurine. Proc West Pharmacol Soc 50:8–15PubMedGoogle Scholar
  22. Saransaari P, Oja SS (2000) Taurine and neural cell damage. Amino Acids 19:509–526PubMedCrossRefGoogle Scholar
  23. Schechter MD, Meehan SM (1995) The lethal effects of ethanol and cocaine and their combination in mice: implications for cocaethylene formation. Pharmacol Biochem Behav 52:245–248PubMedCrossRefGoogle Scholar
  24. Sturman JA (1993) Taurine in development. Physiol Rev 73:119–147PubMedGoogle Scholar
  25. Takatani T, Takahashi K, Uozumi Y, Shikata E, Yamamoto Y, Ito T, Matsuda T, Schaffer SW, Fujio Y, Azuma J (2004) Taurine inhibits apoptosis by preventing formation of the Apaf-1/caspase-9 apoptosome. Am J Physiol Cell Physiol 287:C949–C953PubMedCrossRefGoogle Scholar
  26. Taranukhin A, Taranukhina E, Saransaari P, Djatchkova I, Pelto-Huikko M, Oja SS (2008) Taurine reduces caspase-8 and caspase-9 expression induced by ischemia in the mouse hypothalamic nuclei. Amino Acids 34:169–174PubMedCrossRefGoogle Scholar
  27. Taranukhin A, Taranukhina E, Saransaari P, Djatchkova I, Pelto-Huikko M, Oja SS (2009) Taurine protects immature cerebellar granule neurons against acute alcohol administration. Adv Exp Med Biol 643:159–167PubMedCrossRefGoogle Scholar
  28. Taranukhin AG, Taranukhina EY, Saransaari P, Podkletnova IM, Pelto-Huikko M, Oja SS (2010) Neuroprotection by taurine in ethanol-induced apoptosis in the developing cerebellum. J Biomed Sci 17(Suppl 1):S12PubMedCrossRefGoogle Scholar
  29. Taranukhin AG, Taranukhina EY, Saransaari P, Pelto-Huikko M, Podkletnova IM, Oja SS (2012) Taurine protects cerebellar neurons of the external granular layer against ethanol-induced apoptosis in 7-day-old mice. Amino Acids. doi:10.1007/s00726-012-1254-6Google Scholar
  30. Ulrich-Merzenich G, Zeitler H, Vetter H, Bhonde RR (2007) Protective effects of taurine on endothelial cells impaired by high glucose and oxidized low density lipoproteins. Eur J Nutr 46:431–438PubMedCrossRefGoogle Scholar
  31. Warren KR, Bast RJ (1988) Alcohol-related birth defects: an update. Public Health Rep 103:638–642PubMedGoogle Scholar
  32. Wiberg GS, Trenholm HL, Coldwell BB (1970) Increased ethanol toxicity in old rats: changes in LD50, in vivo and in vitro metabolism, and liver alcohol dehydrogenase activity. Toxicol Appl Pharmacol 16:718–727PubMedCrossRefGoogle Scholar
  33. Wu JY, Wu H, Jin Y, Wei J, Sha D, Prentice H, Lee HH, Lin CH, Lee YH, Yang LL (2009) Mechanism of neuroprotective function of taurine. Adv Exp Med Biol 643:169–179PubMedCrossRefGoogle Scholar
  34. Zhang B, Yang X, Gao X (2010) Taurine protects against bilirubin-induced neurotoxicity in vitro. Brain Res 1320:159–167PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Andrey G. Taranukhin
    • 1
    • 2
  • Pirjo Saransaari
    • 1
  • Simo S. Oja
    • 3
  1. 1.University of Tampere Medical SchoolTampereFinland
  2. 2.Laboratory of Comparative Somnology and NeuroendocrinologySechenov Institute of Evolutionary Physiology and BiochemistrySt.-PetersburgRussia
  3. 3.Department of PediatricsTampere University HospitalTampereFinland

Personalised recommendations